Leyi Zheng

Combination of comprehensive two-dimensional prostate cancer cell membrane chromatographic system and network pharmacology for characterizing membrane binding active components from Radix et Rhizoma Rhei and their targets.

Xuan Ding, Y. Chai, Zhenyu Zhu, 2018, Journal of chromatography. A.

Comparative two‐dimensional HepG2 and L02/ cell membrane chromatography/ C18/ time‐of‐flight mass spectrometry for screening selective anti‐hepatoma components from Scutellariae Radix

Y. Chai, Zhenyu Zhu, Xiaofei Chen, 2019, Journal of pharmaceutical and biomedical analysis.

Enantiospecific determination of arotinolol in rat plasma by LC-MS/MS: application to a stereoselective pharmacokinetic study.

Z. Hong, Leyi Zheng, Z. Qian, 2015, Journal of pharmaceutical and biomedical analysis.

Identification of Annexin A2 as a target protein for plant alkaloid matrine.

Yifeng Chai, Leyi Zheng, Diya Lv, 2017, Chemical communications.

Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.

Yan Cao, Xiaoyu Li, Z. Hong, 2017, Chemistry.

Comprehensive two-dimensional APTES-decorated MCF7-cell membrane chromatographic system for characterizing potential anti-breast-cancer components from Yuanhu–Baizhi herbal medicine pair

Xuan Ding, Z. Hong, Y. Chai, 2017, Journal of food and drug analysis.

Development of 3-mercaptopropyltrimethoxysilane (MPTS)-modified bone marrow mononuclear cell membrane chromatography for screening anti-osteoporosis components from Scutellariae Radix

Jiacan Su, Y. Chai, Yue Liu, 2020, Acta pharmaceutica Sinica. B.